Sort
78,016 grants matching “breast cancer”
Mapping the single cell state basis of metastasis in space and time
$679,564Andrew Josef Ewald · Johns Hopkins University · U01 · FY2023 · CA
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
$679,559Janelle Wilder Coughlin · Johns Hopkins University · R01 · FY2023 · CA
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$679,536Corinne E. Joshu · Johns Hopkins University · R01 · FY2020 · CA
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$679,508Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry
$679,495Mia Hashibe · University Of Utah · R01 · FY2022 · CA
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
$679,482Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
$679,469Kevin Charles Oeffinger · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
NOVEL APPROACHES TO ANTITUMOR DRUG DESIGN
$679,290University Of Arizona · R35 · FY2000 · CA
Population-Based Evaluation of Artificial Intelligence for Mammography Prior to Widespread Clinical Translation
$679,234Christoph I Lee · University Of Washington · R01 · FY2022 · CA
Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures
$679,233D Joseph Jerry · University Of Massachusetts Amherst · U01 · FY2015 · ES
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
$679,205Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
ANDROGEN RECEPTOR-TARGETED TREATMENT FOR THERAPEUTICALLY CHALLENGING BREAST CANCER
$679,196University Of Tennessee · · FY2021 · Defense Health Agency
Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells
$679,188Mark Jesus Magbanua · University Of California, San Francisco · R01 · FY2024 · CA
Medical University of South Carolina NCORP Minority/Underserved Community Site
$679,181Chanita A Hughes-Halbert · Medical University Of South Carolina · UG1 · FY2015 · CA
Regulatory Validation of Standardized Clinical Immunohistochemistry Controls
$679,166Steven A Bogen · Boston Cell Standards Inc · R44 · FY2015 · CA
IGF::OT::IGF EVALUATION OF AGENTS/PROTOCOLS THAT INHIBIT TWO MAJOR PATHWAYS INVOLVED IN HUMAN URINARY BLADDER CANCER(PI3K, EGFR) AND PROTOCOLS TO REDUCE THEIR TOXICITY
$679,103Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2015 · CA
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity
$679,079Kevin Sean Kimbro · North Carolina Central University · R01 · FY2022 · MD
Bone Response to Soy Isoflavones in Women
$678,966D.lee Alekel · Iowa State University · R01 · FY2007 · AR
Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)
$678,927Kathryn E Flynn · Medical College Of Wisconsin · R01 · FY2024 · CA
Insulin Resistance and Breast Cancer Prognosis in Black & White Women
$678,794Nina A Bickell · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · CA
Career Development in Pediatric and Medical Oncology
$678,791Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2019 · CA
The Effects of Vitamin D on Mammographic Density and Breast Tissue
$678,786Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2016 · CA
Developing Nano Technology for HER2 Directed Therapy
$678,715Ajay Nmn Rana · University Of Illinois At Chicago · R01 · FY2019 · CA
Risk prediction methods
$678,702Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
POLYOMA HOST INTERACTIONS LEADING TO TUMOR DEVELOPMENT
$678,691Harvard University (Medical School) · R01 · FY2001 · CA